MLNT - Melinta Therapeutics EPS misses by $0.48 beats on revenue August, 09 2019 07:31 AM Melinta Therapeutics Inc - Ordinary Shares Melinta Therapeutics (NASDAQ:MLNT): Q2 GAAP EPS of -$3.07 misses by $0.48.More news on: Melinta Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...